Bank of America
NERV icon

Bank of America’s Minerva Neurosciences NERV Stock Holding History

Bank of America’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$241K Buy
39,970
+39,919
+78,273% +$229K ﹤0.01% 5262
2025
Q4 		$205 Buy
51
+1
+2% +$4 ﹤0.01% 6695
2025
Q3 		$106 Sell
50
-3
-6% -$6 ﹤0.01% 7848
2025
Q2 		$91 Buy
53
+7
+15% +$11 ﹤0.01% 7982
2025
Q1 		$78 Buy
46
+1
+2% +$2 ﹤0.01% 7886
2024
Q4 		$100 Sell
45
-12
-21% -$28 ﹤0.01% 7733
2024
Q3 		$152 Sell
57
-112
-66% -$326 ﹤0.01% 7629
2024
Q2 		$539 Buy
169
+44
+35% +$119 ﹤0.01% 7344
2024
Q1 		$322 Sell
125
-3
-2% -$18 ﹤0.01% 7311
2023
Q4 		$787 Buy
+128
New +$732 ﹤0.01% 7232
2023
Q1 		– Sell
-6
Closed -$10 – 8119
2022
Q4 		$10 Buy
+6
New +$26 ﹤0.01% 8079
2022
Q2 		– Sell
-18
Closed – – 8253
2022
Q1 		$0 Sell
18
-86
-83% -$528 ﹤0.01% 8583
2021
Q4 		$1K Sell
104
-924
-90% -$8.7K ﹤0.01% 8075
2021
Q3 		$14K Sell
1,028
-4,334
-81% -$65.2K ﹤0.01% 7489
2021
Q2 		$99K Buy
5,362
+844
+19% +$18.2K ﹤0.01% 6525
2021
Q1 		$106K Buy
4,518
+1,929
+75% +$48.2K ﹤0.01% 6366
2020
Q4 		$48K Buy
2,589
+852
+49% +$21.5K ﹤0.01% 6342
2020
Q3 		$44K Sell
1,737
-556
-24% -$15K ﹤0.01% 6061
2020
Q2 		$66K Sell
2,293
-459
-17% -$26.9K ﹤0.01% 5856
2020
Q1 		$133K Sell
2,752
-388
-12% -$23.4K ﹤0.01% 5350
2019
Q4 		$179K Sell
3,140
-1,113
-26% -$49.1K ﹤0.01% 5698
2019
Q3 		$264K Sell
4,253
-4,242
-50% -$240K ﹤0.01% 5494
2019
Q2 		$383K Buy
8,495
+6,635
+357% +$332K ﹤0.01% 5243
2019
Q1 		$117K Sell
1,860
-692
-27% -$41.6K ﹤0.01% 5796
2018
Q4 		$138K Buy
2,552
+371
+17% +$27.2K ﹤0.01% 5742
2018
Q3 		$219K Buy
2,181
+1,021
+88% +$76.7K ﹤0.01% 5445
2018
Q2 		$77K Buy
1,160
+129
+13% +$7.83K ﹤0.01% 5926
2018
Q1 		$52K Sell
1,031
-79
-7% -$3.8K ﹤0.01% 6028
2017
Q4 		$54K Sell
1,110
-348
-24% -$17.3K ﹤0.01% 6034
2017
Q3 		$88K Buy
1,458
+708
+94% +$40.6K ﹤0.01% 5722
2017
Q2 		$53K Sell
750
-83
-10% -$5.37K ﹤0.01% 5851
2017
Q1 		$54K Buy
833
+357
+75% +$27.7K ﹤0.01% 5894
2016
Q4 		$45K Buy
476
+367
+337% +$37.5K ﹤0.01% 5980
2016
Q3 		$12K Buy
109
+71
+187% +$6.89K ﹤0.01% 6323
2016
Q2 		$3K Sell
38
-61
-62% -$3.88K ﹤0.01% 6808
2016
Q1 		$5K Buy
+99
New +$4.23K ﹤0.01% 6571

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM

Bank of America's NERV Position: Q1 2026 in Review

Bank of America increased its Minerva Neurosciences (NERV) stake by 78,273% in Q1 2026, buying an estimated $229K and bringing the position to 39,970 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #5262.

Bank of America first reported a position in NERV in Q1 2016 and has held it in 36 quarters since. The position peaked at $383K in Q2 2019. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Bank of America held 39,970 shares of Minerva Neurosciences worth $241K as of Q1 2026.
  • Bank of America bought 39,919 Minerva Neurosciences shares in Q1 2026, an estimated $229K.
  • Minerva Neurosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5262 holding.
  • Bank of America first reported a position in Minerva Neurosciences in Q1 2016 and has held it in 36 quarters since.
  • Bank of America's Minerva Neurosciences position peaked at $383K in Q2 2019.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.